About Biotechnology 2023

Longdom Group SA takes huge pleasure in attracting all the participants from around the globe to attend the 5^th International Conference on Biotechnology, Biomedicines, and Genetic Engineering, going to be held on October 09-11, 2023 | in Paris, France.

The conference's theme is "Biotechnology as a Trajectory for Future Lives," and participants may submit their research in the form of oral presentations, posters, or videos on any subject.

The Biotechnology 2023 conference is the perfect venue for scientists, researchers, young researchers, industrial delegations, student groups, and citizens to discuss recent advancements in fields like biotechnology and bioengineering, agricultural, food, plant, industrial biotechnology, genomics and microbiome, immunotherapies, tissue engineering, antibody-based therapies and vaccines, nanomedicine, combination cancer therapy and immunotherapy, genetic engineering, and more. Genetic Engineering investigations were conducted in vivo and in vitro.

At this event, participants will have the opportunity to learn about recent biotechnology advances, participate in conversations about topics that interest them, and forge new professional relationships, partnerships, and collaborations. Participants in breakthroughs in biotechnology would know the necessity to integrate sustainable practices into the creation of technologies and goods that benefit humanity.

We believe that the Biotechnology 2023 conference will considerably increase our understanding of the most cutting-edge scientific fields of biotechnology.

Why Attend?

1. Discover the state of research today
2. Meet international colleagues and experts
3. Tour a showcase of cutting-edge technology
4. Interact with editors of the top journals in your field
5. Engage in global networking and certification
6. Launch a brand, and explore many more opportunities
7. Career Advancement
8. Exposure to new ideas and perspectives
9. Travel and Cultural Experiences

Target Audience:

1. Researchers
2. Doctors
3. Business delegates
4. Eminent personalities
5. Head of the department
6. CEO’s biotech company
7. Pharmacists
8. Academicians’
9. R &D heads from the relevant field
10. Professors, Associate and Assistant professors
11. Directors/ Managers
12. Presidents/ Vice Presidents
13. Other experts in Biotechnology

Biotechnology:

Session 01: Biotechnology & Bioengineering

People have been using Biotechnology for a long time as a means of selecting breeding and enhancing agriculturally essential organisms. The creation of disease-resistant wheat varieties through cross-breeding various wheat varieties until the desired disease resistance was present in the resulting new selection is an example of ancient agricultural biotechnology. Technologies based on genetic engineering will make it easier to improve health conditions in underdeveloped nations. Genetic Bioengineering might result in better keeping qualities that make it simpler to transport recently produced goods, give consumers access to nutritionally valuable whole foods, and stop the rot, damage, and nutrient loss. Gains from Agriculture Crop production is doubled, crop protection is improved, food processing is improved, the nutritional value is improved, environmental benefits are enhanced, the flavor is enhanced, and new products are produced thanks to biotechnology. Using living organisms (or components of living organisms) to make a product, enhance plants, trees, or animals, or produce microbes with specialized functions is referred to as biotechnology. The term "agricultural biotechnology" refers to the use of biotechnology techniques to improve crops and eutherian mammals. The biotechnology of crops can be the sole subject of this dissertation. Many tools and components of traditional breeding methods, plant physiology, etc. are included in biotechnology.

1. Gene editing and gene therapy
2. Synthetic biology
3. Biosensors
4. Stem cell research

Session 02: Bioprocess Engineering

To create products from renewable feedstocks, Bioprocess Engineering integrates engineering and biotechnology. Basic bio-molecular analysis of proteins, enzymes, and microorganisms is included in this field, along with work on biosensors, bio separations, and bioreactors. Uses include food processing and preservation, the manufacture of pharmaceuticals, nutraceuticals, and sweeteners, the treatment of air and waste, the use of microfluidics for bioreactors and DNA chips, bioenergy, and pulp and paper industry applications in Biotechnology. Applications in Biomedicine such as drug metabolism, tissue engineering, and bio-based medicinal methods are naturally connected.

1. Biomolecular Engineering
2. Biocatalysts & Biotransformation
3. Biosynthesis and Metabolic Engineering

Session 03: Microbiology, virology, cytology, and immunology

The study of microorganisms, such as bacteria, viruses, fungi, and protozoa, is known as Microbiology. There are numerous real-world uses for this sector, including as in biotechnology, agriculture, and medicine. The study of viruses, which are tiny infectious agents that can infect people, animals, and plants and cause a variety of diseases, is known as Virology. Creating treatments and vaccinations requires a thorough understanding of the structure and operation of viruses. Cells, the fundamental building blocks of life, are the subject of Cytology. This discipline includes a broad range of topics, including cell structure and function, cell division, and the emergence of cancer. The immune system, which protects the body from pathogens and other external substances, is the subject of the science of Immunology. The investigation of vaccinations, autoimmune conditions, and cancer immunotherapy falls under this category. In general, these disciplines are linked and play important roles in comprehending and battling infectious diseases. We eagerly anticipate learning more in the future about these exciting study areas and any potential applications they may have.

1. Microbial ecology and diversity
2. Emerging viruses and infectious diseases
3. Host-pathogen interactions
4. Cancer immunotherapy

Session 04: Biological macromolecules interactions

The interactions of Biological macromolecules, which are crucial for the operation of living creatures, will be covered in this session. The four primary types of biological macromolecules—proteins, nucleic acids, carbohydrates, and lipids—interact with one another in a variety of ways. For signaling cascades and enzymatic activities, protein-protein interactions are essential, whereas protein-DNA interactions regulate gene expression. Lipid-protein interactions are critical in membrane construction and function, while carbohydrate-protein interactions in Biotechnology are crucial for cell adhesion and communication. The development of novel therapeutic strategies and the advancement of our understanding of biology depends critically on our ability to comprehend the complex interactions between these macromolecules.

1. Structural biology of macromolecule interactions
2. Protein-protein interactions in disease and drug development
3. DNA-protein interactions in gene regulation and genome organization
4. Carbohydrate-protein interactions in host-pathogen interactions and immune response

Session 05: Pharmaceutical Biotechnology

Analyzing a drug's stability, interactions with the body, shelf life, and administration system is important before it is developed. The Pharmaceutical industry has advanced to the point that it now uses Genetic Engineering to produce 3rd generation medications, such as long-lasting and quick-acting insulin, erythropoietin, and the GM microbe that was utilized to enhance the bioproduct of particular interest. a requirement for enhancing innovative Pharmaceuticals for rising illnesses.

1. Advances in bioprocessing for the production of biologics and biosimilars
2. Development of novel drug delivery systems using biotechnology
3. Emerging technologies in pharmaceutical biotechnology, such as CRISPR and CAR-T therapy
4. Bioprocess optimization and scale-up for the production of high-quality biologics
5. Biotechnology-based approaches to vaccine development and production

Session 06: Bioinformatics & Biocomputing

The most recent developments in computational biology and their influence on biomedical research were discussed at the Bioinformatics & Biocomputing session. To demonstrate the effectiveness of bioinformatics tools in the processing and interpretation of massive amounts of biological data, researchers from all over the world presented their work on issues like genomics, proteomics, and systems biology. The advancement of machine learning and deep learning methods for predictive modeling, as well as the integration of many data types, including transcriptomics, metabolomics, and epigenomics, were the main topics of discussion. Along with learning about new applications and tools for data analysis and visualization, attendees also received introductions to cloud computing platforms for big data analysis. The significance of cooperation between biologists, computer scientists, and mathematicians to handle difficult biological issues and progress in the area of bioinformatics was underlined at the sessions.

1. Next-generation sequencing data analysis
2. Epigenomics and epigenetic regulation
3. Single-cell analysis and spatial transcriptomics
4. Bioinformatics tools and software development

Session 07: Agricultural, Food, Plant, and Industrial Biotechnology

People have been using Biotechnology for a long time as a means of selecting breeding and enhancing agriculturally essential organisms. The creation of disease-resistant wheat varieties through cross-breeding various wheat varieties until the desired disease resistance was present in the resulting new selection is an example of ancient Agricultural Biotechnology. Technologies based on genetic engineering will make it easier to improve health conditions in underdeveloped nations. Genetic Engineering might result in better keeping qualities that make it simpler to transport recently produced goods, give consumers access to nutritionally valuable whole foods, and stop the rot, damage, and nutrient loss. Crop productivity can be raised, crop protection can be improved, food processing can be improved, nutritional value can be improved, environmental benefits can be realized, and new products may be produced. Using living organisms (or components of living organisms) to make a product, enhance plants, trees, or animals, or produce microbes with specialized functions is referred to as biotechnology. The term "Agricultural Biotechnology" refers to the use of biotechnology techniques to improve crops and eutherian mammals. The biotechnology of crops can be the sole subject of this dissertation. Many tools and components of traditional breeding methods, plant physiology, etc. are included in biotechnology.

1. Advances in gene editing technology for crop improvement
2. Sustainable agriculture and food systems
3. Industrial biotechnology for the production of renewable fuels and chemicals
4. Plant biotechnology for the development of new pharmaceuticals
5. Biotechnology and food safety

Session 08: Biocatalysts & Metabolic Engineering

Biocatalysts are essential for metabolic engineering because they offer practical and environmentally friendly ways to produce and synthesize chemicals. Industrial biotechnology and the development of new biocatalysts through genetic engineering and protein design are becoming more and more feasible. With Metabolic Engineering, cells' internal metabolic processes can be improved, producing useful compounds and materials. The discipline of biotechnology could undergo a revolution thanks to the incorporation of biocatalysts and Metabolic Engineering, resulting in brand-new approaches to resource usage and production. To explore the most recent advancements in metabolic engineering and biocatalysts as well as their applications in bioprocessing, bioenergy, and Biomedicine, this session will bring together specialists from academia, industry, and government.

1. Advances in biocatalyst discovery and engineering
2. Synthetic biology for metabolic engineering
3. Computational design of biocatalysts and metabolic pathways
4. Applications of biocatalysts and metabolic engineering in the food industry

Session 09: Stem cell and Regenerative Medicine

We can learn about the characteristics of Stem cells and how a healthy body develops by studying them. Our stem cells were unable to maintain their capacity for limitless cell division in the face of pressure and the frequent emergence of numerous diseases. By enhancing the cell on the outside and injecting it, stem cells can treat disorders that are currently incurable by medical means, such as cardiac arrest.

1. Advances in stem cell research: current status and prospects
2. Ethical considerations in stem cell research and therapy
3. Induced pluripotent stem cells (iPSCs) for disease modeling and drug discovery
4. Stem cell therapies for musculoskeletal disorders and injuries
5. Stem cell-based approaches for diabetes treatment

Session 10: Synthetic Biology

In the rapidly expanding interdisciplinary subject of Synthetic Biology, biological systems, and technologies are designed and built for several uses. The most recent developments in synthetic biology, such as those in metabolic engineering, gene circuit design, and genome editing, will be discussed in this session. Leading academics and business professionals will also speak to us about the ethical, legal, and social ramifications of synthetic Biology and how it might affect society. The creation and use of synthetic biology technologies and techniques will be the subject of discussions and workshops open to participants. This session will present a special opportunity to learn, network, and remain current on the most recent advancements in synthetic biology, whether you are a researcher, an entrepreneur, or simply interested in the area.

1. Synthetic gene circuits
2. Biosensors
3. Ethical, legal, and social implications
4. Bioinformatics
5. Genome editing

Session 11: 3D Cultures & Organoids

Organoids and 3D Cultures are effective in vitro research tools for understanding intricate biological systems. Researchers can more accurately replicate the 3D environment and cellular interactions occurring in vivo thanks to these models. Organoids in particular is helpful for disease modeling and medication discovery since they may recreate tissue-specific architecture and functions. Optimizing and standardizing these cultural systems for repeatable outcomes still presents difficulties, though. For improving our understanding of human Biology and illness, 3D cultures and organoids show considerable promise.

1. Development of novel 3D culture and organoid systems for disease modeling and drug screening.
2. Advances in imaging and characterization techniques for studying 3D cultures and organoids.
3. Application of 3D cultures and organoids in personalized medicine and regenerative therapy.
4. Challenges and solutions in standardizing and scaling up 3D culture and organoid production for research and clinical use.

Session 12: Omics Technologies

Omics Technologies are effective instruments that allow a thorough analysis of biological systems at different levels. Each one offers distinct insights into the intricate workings of life, and they include genomes, transcriptomics, proteomics, metabolomics, and epigenomics. Omics technologies will be a key topic of discussion at the Biotechnology International Conference in 2023, with researchers and industry professionals showcasing their most recent discoveries and advancements. The development of novel omics platforms and approaches, applications in drug discovery, precision medicine, and agriculture, as well as advancements in data analysis and integration, will be among the major themes covered. The sessions will highlight the enormous potential of omics technologies to advance Biotechnology research and development in the genre

1. Integration of multi-omics data for precision medicine
2. Single-cell omics technologies and their applications
3. Advances in metagenomics and microbiome analysis
4. Omics-based approaches for personalized nutrition and wellness
5. Omics technologies for crop improvement and sustainable agriculture

Session 13: Genomics and Microbiome

The role of Genetics in precision medicine has been changed by recent advancements in sequencing technologies, which have provided previously unreachable insights into disease processes and tailored treatment options. It is becoming increasingly clear that the trillions of bacteria that make up the Human Microbiome, which is present both within and outside the body, play a substantial influence on human health and disease, with implications for treatments and diagnostics. To analyze the vast amounts of data in the field of genetics and make breakthrough discoveries and tailored medical treatment techniques possible, machine learning algorithms are swiftly emerging as critical tools. Researchers in genetics, immunology, microbiology and bioinformatics must work together interdisciplinary to fully comprehend the potential of the microbiome-host interaction. Our knowledge of human health and illness may significantly shift.

1. The impact of the gut microbiome on cancer therapy response and toxicity
2. Metagenomic sequencing for infectious disease diagnosis
3. The role of the skin microbiome in skin health and disease
4. Host-microbe interactions in the lung microbiome
5. The impact of the oral microbiome on systemic health

Session 14: AI in Biotechnology

Innovative advancements in a variety of sectors, including medicine, agriculture, and environmental science, have resulted from the fusion of AI and biotechnology. Artificial intelligence (AI)-powered tools like machine learning and natural language processing are accelerating scientific discoveries by facilitating the interpretation of complex biological data. The development of more effective medications and the identification of novel therapeutic targets have been made possible by the application of AI in drug discovery. Artificial intelligence (AI)-enabled technologies are advancing sustainable agricultural practices by increasing crop yields and lowering the usage of toxic pesticides. Experts will talk about the most recent developments and prospects of AI in Biotechnology at the 2023 international conference on biotechnology, emphasizing the revolutionary effects of these technologies on numerous industries.

1. AI-based drug discovery and development
2. Integration of AI and genomics for precision medicine
3. AI-powered medical imaging for disease diagnosis and treatment
4. Predictive modeling for personalized nutrition and wellness
5. AI-enabled protein design and engineering for biopharmaceuticals

Session 15: Bioenergy

Bioenergy is a form of clean energy that can be produced from materials derived from organic sources. Any natural material that retains chemical energy from sunlight as biomass is known as such. It would use sugarcane, wood waste, straw, fertilizer, and a variety of other agricultural byproducts as fuel. It's a very basic form of biofuel, which is gasoline derived from biological sources. In a broader sense, it includes social, economic, logical, and specialized sectors related to harnessing natural hotspots for energy, as well as biomass, the organic material used as a biofuel. This is a common misconception since bioenergy is the energy that is removed from biomass, which is the fuel, and bioenergy is the vitality that is contained in the fuel.

1. Nanobiotechnology for Disease Diagnosis and Therapy
2. Biopolymers for Sustainable Packaging
3. Bioenergy Production from Microalgae
4. Nanoparticle-Based Biosensors for Environmental Monitoring
5. Biopolymers for Tissue Engineering

Session 16: Biotechnology for the Environment and Energy

The newest developments in the field of Biotechnology with an emphasis on sustainability and energy production will be presented at the Biotechnology for the Environment and Energy conference in 2023. Leading academics, researchers, and business professionals will gather at the session to talk about the most recent developments in biotechnology for waste disposal, renewable energy production, and environmental restoration. The speakers will cover a variety of subjects, including bioremediation, biofuels, biomaterials, and bioprocess engineering. The field's most recent achievements and difficulties will be highlighted by keynote speakers, who will also offer insight into the direction biotechnology may take going forward for environmental and energy applications. Professionals in the area have a rare chance to network, work together, and exchange ideas at the sessions, which will advance Biotechnology advancements for a sustainable future.

1. Synthetic biology for sustainable production of fuels, chemicals, and materials
2. Advances in bioremediation and phytoremediation for environmental cleanup
3. New biocatalysts and bioprocesses for sustainable production of high-value chemicals
4. CRISPR-Cas and other gene editing technologies for environmental and energy applications
5. Biotechnology solutions for circular economy and waste reduction

Biomedicines:

Session 01: Biopharmaceutical Biomedicine

the most recent developments in biologic and Biosimilar drug production, including fresh methods for doing so as well as creative methods for quality assurance and process validation. innovations in precision oncology and personalized medicine, which use genetic and molecular data to customize medicines to specific patients and enhance treatment outcomes. the creation of novel Biomedicines to treat uncommon diseases and ailments, many of which are not well addressed by conventional drug development pipelines but which yet have significant unmet medical needs. The use of machine learning and artificial intelligence in the discovery and development of new drugs, including the identification of novel therapeutic targets, improvement of clinical trial layout, and prognostication of patient outcomes. The ethical challenges involved in the creation and application of Biopharmaceuticals and Biomedicines, including issues of equity, affordability, and access, as well as privacy and patient autonomy concerns.

1. Gene therapy
2. Immunotherapy
3. RNA therapeutics:
4. Microbiome-based therapies:
5. Digital health and wearables

Session 02: Immunotherapies

A rapidly developing field of medicine called Immunotherapy has shown considerable promise in treating several illnesses, including cancer and autoimmune diseases. Monoclonal antibodies, checkpoint inhibitors, and CAR-T cell therapy are a few examples of immunotherapies that have received regulatory agency approval and are now being used in clinical settings. There are still issues that need to be resolved, such as finding biomarkers for patient selection and enhancing response durability. Researchers, doctors, and business experts will get the chance to present their most recent findings and talk about the potential of immunotherapies at the Biomedicines International Conference in 2023. The development of novel immunotherapies, the use of biomarkers for patient selection, and the management of immune-related adverse events are just a few of the subjects that will be covered during the session.

1. CAR-T cell therapy
2. Checkpoint inhibitors
3. Personalized cancer vaccines
4. Combination therapies
5. Microbiome-based therapies

Session 03: Nanomedicine, Combination Cancer Therapy, and Immunotherapy

Some of the most exciting fields of Biotechnology research are Nanomedicine, combination cancer therapy, and immunotherapy. Attendees may anticipate learning about the most recent advancements and discoveries in these fields at the International Biotechnology Conference in 2023, which is expected to feature these topics as major themes. To develop targeted drug delivery systems that can administer medications to particular regions of the body, such as cancer cells, with greater precision and fewer adverse effects, nanomedicine uses nanotechnology. Combination cancer therapy refers to the application of several therapies, including chemotherapy, radiation, and targeted therapy, to combat cancer cells from a variety of angles and enhance therapeutic results Using the body's immune system to combat cancer cells, immunotherapy is one method of cancer treatment. Researchers in the field of biotechnology has been studying it in great detail since it has demonstrated significant promise in the treatment of a variety of malignancies. All things considered, the nexus of nanomedicine, combination cancer therapy, and Immunotherapy is a rapidly developing field of biotechnology that has the potential to transform the way cancer is treated and enhance patient outcomes.

1. Nanomedicine and Nanobiotechnology (ICONAN)
2. World Congress on Cancer and Therapy
3. Annual Meeting of the American Association for Cancer Research (AACR)
4. European Society for Medical Oncology (ESMO) Congress
5. Immunotherapy and Cancer (ITOC)

Session 04: Antibody-based therapies and Vaccines

New Antibody-based treatments: Recent developments in antibody engineering have made it possible to create next-generation antibody-based treatments that are more effective and targeted than classic monoclonal antibodies in Biomedicine Vaccines. The most recent advances in antibody engineering and the promise of these novel medicines to treat conditions including cancer, autoimmune disorders, and infectious diseases could be the main topics of this session.

COVID-19 antibody-based treatments: The need for efficient Biomedicines to treat viral infections has been brought to light by the COVID-19 pandemic. This discussion could focus on the use of antibody-based treatments, such as convalescent plasma therapy, monoclonal antibody therapy, and polyclonal antibody therapy, to treat COVID-19.

1. Antibody Engineering & Therapeutics
2. World Vaccine Congress
3. American Society of Hematology Annual Meeting
4. Vaccines and Immunology
5. Immuno-Oncology 360°

Session 05: Novel targets in various therapeutic areas: cardiovascular, vascular, hematology, oncology, neurology, orthopedics, dermatology, ophthalmology

To create treatments for atherosclerosis and peripheral artery disease, researchers in the domains of Cardiovascular and vascular science are looking into novel targets, such as modifying the Want signaling pathway and blocking leukotriene B4 receptor 1. Hematologists believe that gene editing and gene therapy techniques, as well as the use of small molecule inhibitors that target particular enzymes and pathways, are viable targets for the treatment of blood disorders such as sickle cell disease and thalassemia. With potential targets like DNA damage repair pathways, the immunological checkpoint protein TIM-3, and the tumor microenvironment, Oncology research is concentrated on creating targeted medicines against certain mutations and biomarkers. In neurology, new targets for the treatment of neurodegenerative conditions including Alzheimer's and Parkinson's are being investigated. They include developing monoclonal antibodies that target tau and alpha-synuclein as well as medications that attempt to lessen neuroinflammation. Promising targets for the creation of novel therapies are also being identified in the fields of orthopedics, dermatology, and ophthalmology research. These include the use of growth factors for tissue repair in orthopedics, control of the skin microbiome in dermatology, and the creation of gene therapies for inherited retinal disorders in Ophthalmology.

1. Cardiovascular
2. Hematology
3. Oncology
4. Neurology
5. Ophthalmology

Session 06: Biosensors and Bioimaging

The ability to detect and observe biological substances and processes is made possible by crucial Biomedical technologies like biosensors and bioimaging. The creation of novel imaging agents and the coupling of biosensors with microfluidic devices are just two examples of cutting-edge research and developments in biosensors and bioimaging that will be presented at the Biomedicines International Conference in 2023. Clinical applications of biosensors and bioimaging in illness diagnosis, drug development, and personalized medicine, as well as their promise for enhancing patient outcomes and lowering healthcare costs, will be covered by subject matter experts. The session will offer a forum for cutting-edge research in the fields of Biosensors and Bioimaging to be discussed by academics, medical experts, and business executives. The session's overall goal is to support the transition of biosensor and bioimaging technologies from the lab to the clinic and to speed up the creation of cutting-edge diagnostic and treatment tools for patients all over the world.

1. Nanoparticle-based biosensors
2. Wearable biosensors
3. Fluorescence microscopy
4. Point-of-care diagnostic devices
5. Artificial intelligence and machine learning in bioimaging

Session 07: Biomaterials and Tissue Engineering

By offering a substrate for cell growth and differentiation into functional tissue, Biomaterials are essential in tissue engineering. To generate live tissues for use in medicine, the interdisciplinary area of tissue engineering incorporates ideas from biology, engineering, and materials science. New therapies have been developed for several medical problems, including bone and cartilage abnormalities, skin wounds, and organ failure because of advancements in biomaterials and tissue engineering. A promising tool for Tissue engineering and regenerative medicine is bioprinting, a method for producing intricate three-dimensional tissue constructs. Upcoming advancements in biomaterials and tissue engineering have the potential to significantly enhance patient outcomes and change the landscape of regenerative medicine.

1. 3D bioprinting for tissue engineering and regenerative medicine
2. Development of biomaterials for targeted drug delivery
3. Use of stem cells and gene editing in tissue engineering
4. Biodegradable polymers for implantable medical devices
5. Smart biomaterials for sensing and monitoring physiological conditions

 Genetic Engineering:

Session 01: Recent Advances in Genetic Engineering

The term "Genetic Engineering" refers to the process of changing DNA's genetic makeup, which can be done through nuclear transplantation, gene targeting, and the insertion of modern DNA. The in vitro negative selections are typically carried out via the suicide gene. The gene knockdown and knockings will have an impact on the organisms phenotypic. It's possible that this gene splicing will solve significant problems in human health.

1. Genetic engineering in agriculture
2. Biomanufacturing
3. Gene drives
4. Synthetic biology

Session 02: DNA repair and cellular responses

Understanding DNA repair and cellular responses is essential for creating safe and effective gene therapies in the field of genetic engineering. Experts will talk about the most recent developments in this field at the International Conference on Genetic Engineering in 2023. The study of DNA repair pathways can aid in the detection of genetic changes that may lead to disease as well as the development of methods for repairing or replacing damaged DNA. While creating gene therapies, one must consider cellular reactions to genetic alterations, such as immunological responses. This information can be used by researchers to increase the efficacy and safety of gene therapy treatments. Furthermore, as cancer cells frequently have compromised DNA repair systems, studying DNA repair and biological responses can also help in the development of cancer treatments. Research advances in cellular response and DNA repair have a big impact on how genetic engineering and Biotechnology will develop in the future.

1. Advances in DNA Damage Response and Repair
2. DNA Repair Mechanisms in Human Disease
3. Novel Technologies for Studying DNA Repair
4. Cellular Signaling and DNA Damage Response
5. Targeting DNA Repair in Cancer Therapy

Session 03: Disease modeling

The Genetic Engineering International Conference will feature a keynote address on disease modeling. The use of genetic engineering to build Disease models that can advance our understanding of illnesses and aid in the development of more efficient treatments will be discussed by experts in the area. Creating models for cancer, neurological illnesses, and uncommon genetic diseases will be some of the main areas of study. The most recent developments in Genetic Engineering tools and technologies, which are enabling more accurate and effective disease modeling, will also be covered during the sessions. The ultimate objective of these initiatives is to hasten the discovery of novel treatments and cures for a variety of ailments.

1. Organoid models
2. CRISPR-based models
3. Machine learning and AI
4. Multi-omics approaches
5. Patient-derived models

 Session 04: Gene editing using CRISPR-Cas technology

CRISPR-Cas technology has revolutionized genetic engineering and has immense potential in a wide range of industries, including biotechnology, medicine, and agriculture. Because to CRISPR-precise Cas's and effective gene editing capabilities, genetic mutations can now be corrected and DNA sequences modified with previously unheard-of accuracy. This technology has the potential to provide new treatments for a variety of ailments, including cancer, HIV, and genetic disorders. It also has the potential to increase crop productivity and improve food security. CRISPR-Cas technology is being used, but it also poses ethical and safety issues, and it needs to be carefully regulated and overseen to ensure the responsible use of this potent weapon. International Conferences give scientists, decision-makers, and other interested parties a forum to talk about the most recent research results, exchange best practices, and create rules for the moral and secure application of CRISPR-Cas technology in Genetic Engineering.

1. Precision medicine and gene therapy
2. Agricultural biotechnology
3. Synthetic biology
4. Ethical and regulatory issues

Session 05: mRNA Technology

The success of COVID-19 vaccines based on mRNA has highlighted the potential of this technology as a unique platform for vaccine development. To create vaccines against a variety of infectious diseases, particularly those brought on by new pathogens, researchers can use mRNA technology.

Personalized cancer vaccines can be created thanks to mRNA technology, which has the potential to completely transform the way cancer is treated. Tumor-specific antigens that elicit the immune system's recognition and attack of cancer cells can be encoded by researchers using mRNA.

1. mRNA vaccines for emerging infectious diseases
2. mRNA-based therapies for rare diseases
3. Advances in mRNA delivery systems
4. mRNA technology for tissue engineering
5. Development of mRNA-based cancer immunotherapies

 Session 06: Single Cell Technology

Genetic engineering has been transformed by Single-Cell Technology, which has allowed for the incredibly thorough and detailed study of individual cells. Single-cell sequencing technology has recently made strides that have made it possible to identify uncommon cell types and decipher complex cellular dynamics. The combination of CRISPR/Cas9 gene editing and single-cell technology has created new opportunities for studying the function of genes in individual cells and creating novel therapies. Precision medicine and individualized treatments have been made possible by the application of single-cell analysis to comprehend the molecular underpinnings of disease. Overall, single-cell technology has great potential for expanding our knowledge of cellular biology and human health. It is also set to have a significant impact on the field of Genetic Engineering.

1. Single Cell
2. Single Cell Transcriptomics
3. Single Cell Epigenomics
4. Single Cell Proteomics

Session 07: Synthetic biology

Genetic engineering's fast-expanding field of Synthetic biology has the potential to completely transform a variety of sectors, from agriculture to healthcare. Leading academics and business professionals get together at this worldwide conference to talk about the most recent advancements in synthetic biology and its uses. Genetic circuit design, genome editing, protein engineering, and the creation of new biosensors are discussed. The session will also go through the problems and potential given by this new discipline, as well as the ethical and legal ramifications of Synthetic Biology. The discussions and partnerships sparked by this session will be crucial in determining the direction of synthetic biology because they have the potential to impact many facets of society.

1. Multi-scale
2. CRISPR-based gene editing
3. Computational modeling and machine learning
4. Synthetic biology for sustainability

Session 08: The Advancement of Cell and Gene Therapies

The most recent developments in cell and Gene Treatments, a quickly expanding area of genetic engineering, will be highlighted at the 2023 Genetic Engineering International Conference. Leading scientists and business professionals will speak to attendees about the most recent developments in gene editing, cellular reprogramming, and other cutting-edge technologies that show promise for treating a variety of ailments. The creation of gene treatments for uncommon genetic illnesses, developments in the use of CRISPR-Cas9 technology, and the promise of CAR-T cell therapies for the treatment of cancer are just a few possible conversation topics. There is growing hope about the potential of cell and Gene Therapies to revolutionize how we practice medicine and enhance patient outcomes as a result of the continual advancements in this field of study. The session will offer a special chance for researchers, practitioners, and business leaders to exchange their most recent discoveries, work together on fresh research projects, and examine the potential and problems facing this fascinating sector.

1. Gene Editing Technologies
2. CAR-T Cell Therapy
3. Gene Therapy for Rare Diseases
4. Cell Reprogramming
5. Delivery Strategies for Gene and Cell Therapies

 Session 09: Gene Drives

Gene drives have become a potent tool in Genetic Engineering that could transform attempts to manage illness and conserve biodiversity. Researchers and professionals will present the most recent developments in gene drive technology, including the creation of safer and more accurate gene drive systems, at the International Conference on Genetic Engineering in 2023. The legal framework for gene drive applications, the ethical ramifications of Gene Drive research, and the advantages and disadvantages of using gene drives in the wild will be among the major themes covered. Overall, the session will give scientists and other interested parties a forum to discuss and work together on the appropriate use of gene drive technology.

1. Advancements in CRISPR/Cas9 gene editing technology for developing precise and targeted gene drives.
2. Novel gene drives mechanisms, such as split drive systems and homing endonuclease-based gene drives, aim to improve safety and reduce potential unintended consequences.
3. Exploration of alternative applications for gene drives beyond disease control and conservation, such as in agriculture and pest management.

Session 10: Environmental and Agricultural Applications

The 2023 Genetic Engineering International Conference will bring together specialists and researchers from all over the world to talk about the most recent developments in genetic engineering's use in agriculture and the environment. Genetically modified crops, bioremediation, gene editing methods, and the use of genetic engineering in conservation efforts will all be discussed. The advantages and potential risks of these technologies, as well as moral and legal issues, will be covered in presentations and panel discussions. The session will serve as a forum for communication and knowledge exchange between researchers, business leaders, decision-makers, and other interested parties. The session seeks to contribute to the creation of new and sustainable solutions to some of the most urgent environmental and Agricultural concerns of our day through the sharing of thoughts and research findings.

1. CRISPR-Cas9 gene editing technology and its potential applications in crop improvement and genetic engineering of microorganisms for bioremediation purposes.
2. Developing genetically modified crops with improved resistance to abiotic stresses such as drought, salinity, and extreme temperatures, as well as resistance to pests and diseases.

 Session 11: In vivo and in vitro studies in Genetic Engineering

Genetic engineering in vivo research: In vivo studies are those that are carried out inside a living thing. The effectiveness and safety of genetic therapies and gene editing methods are evaluated in genetic engineering through in vivo experiments. To treat genetic illnesses, researchers are looking into new strategies for delivering therapeutic genes to specific cells within the body. Genetic engineering studies conducted in vitro: Studies referred to as "in vitro" are those that are carried out outside of a living thing, typically in a lab. In vitro investigations are utilized in genetic engineering to comprehend the fundamental mechanisms of genetic processes and to create novel genetic engineering tools and procedures. This includes modifying genes in cell cultures using CRISPR/Cas9 gene editing to examine the consequences of specific genetic changes.

1. In vivo gene editing using CRISPR
2. In vitro organoid models for disease research
3. In vitro genome engineering of non-model organisms
4. Ethical considerations of gene editing in human embryos

Session 12: Statistical Genetics

The field of Statistical Genetics is frequently used in human genetics. It focuses on the statistical method for concluding genetic data. A recent development in statistical genetics is the examination of gene modules in single-cell RNA-seq data using the tool MTGO-SC, which is a critical step in the identification of functional modules in gene interaction networks for comprehending biological processes.

1. Genetic Epidemiology
2. Population Genetics
3. Quantitative Genetics
4. Bioinformatics

 

Market Analysis:

Biotechnology is the use of living organisms, biota, or their products to alter or improve the processes used in the production of medical supplies and drugs. A cutting-edge, multidisciplinary discipline is biotechnology. The public's understanding of biotechnology has grown over time, and many individuals now see it as a promising career path. Only the Biotechnology industry is able to supply the need for cutting-edge drugs and vaccines as the COVID-19 phase draws closer. Biotechnology is without a doubt the best professional path for the foreseeable future.

Because of the rise in fatal diseases and epidemics, Biotechnology will soon become a survivability strategy. Since there are already over 9 million people in the world, we will also require new agricultural and medical technologies, where biotechnology will play a big role in the future.

A CAGR of 17.0% is predicted for the worldwide biotechnology market, which would increase from USD 129.14 billion in 2021 to USD 151.10 billion in 2022. The biotech sector is anticipated to expand at a CAGR of 15.3% and reach USD 267.29 billion by 2026. The biotechnology market will be worth $2.44 trillion by 2028 with a 15.83% CAGR. The global bioeconomic may be valued at more than $20 trillion by 2030 if yearly income growth rates are between 10 and 15 percent. Market expansion is projected for the biotechnology industry between 2021 and 2028. The usage of cutting-edge biotechnology equipment and products is required due to the rising prevalence of chronic diseases, which is what is driving the growth of the biotechnology industry. The market for biotechnology is growing because its use is becoming more widespread.

The anticipated size of the global biotechnology industry, which was forecast to be worth USD 793.87 billion in 2021, is expected to increase to USD 1,683.52 billion by 2030, rising at a remarkable CAGR of 8.7% from 2022 to 2030. Due to the growth of the biotechnology sector in developing nations like China, Japan, and India, the market is being driven by encouraging government efforts.

Biotechnology Societies and Associations in World:

1. American Institute for Medical and Biological Engineering (AIMBE)

2. American Institute of Biological Sciences (AIBS)

3. American Medical Informatics Association (AMIA)

4. American Society of Microbiology (ASM)

5. Biomedical Engineering Society (BMES)

6. Biophysical Society

7. European Molecular Biology Organization (EMBO)

8. Federation of American Societies for Experimental Biology (FASEB)

9. Genetics Society of America (GSA)

10. IEEE Engineering in Medicine and Biology Society (EMBS)

11. Institute for Systems Biology

12. Institute of Biological Engineering (IBE)

Biotechnology companies in Paris, France:

1. Abivax

2. Carmat

3. Cellectis 

4. DBV Technologies

5. DNA Script

6. Enterome

7. GenSight Biologics

8. Global Bioenergies

9. Lysogene

10. Nanobiotix